0
0
1/20/23 at 5:08pm
Organization
The Wall Street Journal
Author
Peter Loftus
30 words
0
Comments
Setback could delay potential commercial introduction of drug called donanemab by at least several months
You are the first to view
https://www.wsj.com/articles/fda-seeks-more-data-on-lillys-alzheimers-drug-candidate-11674172480
Create an account
or login to join the discussion